Bone involvement in pediatric non-Hodgkin's lymphomas

Hematology. 2008 Dec;13(6):348-51. doi: 10.1179/102453308X343464.

Abstract

Data pertaining to primary and secondary osseous involvement in pediatric non-Hodgkin's lymphoma (NHL) are scarce in English literature. Fifty-nine cases of childhood NHL over a period of 3.5 years were reviewed out of which eight had bone involvement, the incidence of skeletal involvement being 13.6%. There were seven males (87.5%) and mean age was 9.9 years (range: 1-15 years). Two patients (25%) had primary bone lymphoma and six cases (75%) were classified as secondary bone lymphoma. Six patients who opted for treatment received chemotherapy; 4/6 (67%) patients are in complete remission at a median follow-up of 41 months (range 19-44 months). Bone involvement was more common in relapsed cases in comparison to de novo presentations.

MeSH terms

  • Adolescent
  • Antineoplastic Agents / therapeutic use
  • Bone Neoplasms / drug therapy
  • Bone Neoplasms / epidemiology*
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Incidence
  • Infant
  • Lymphoma, Non-Hodgkin / drug therapy
  • Lymphoma, Non-Hodgkin / epidemiology*
  • Male
  • Remission Induction
  • Retrospective Studies

Substances

  • Antineoplastic Agents